TABLE OF CONTENTS 1 Research Methodology and Statistical Scope 1.1 Market Definition and Statistical Scope of Gaucher Disease 1.2 Key Market Segments 1.2.1 Gaucher Disease Segment by Type 1.2.2 Gaucher Disease Segment by Application 1.3 Methodology & Sources of Information 1.3.1 Research Methodology 1.3.2 Research Process 1.3.3 Market Breakdown and Data Triangulation 1.3.4 Base Year 1.3.5 Report Assumptions & Caveats 2 Gaucher Disease Market Overview 2.1 Global Market Overview 2.1.1 Global Gaucher Disease Market Size (M USD) Estimates and Forecasts (2017-2028) 2.1.2 Global Gaucher Disease Sales Estimates and Forecasts (2017-2028) 2.2 Market Segment Executive Summary 2.3 Global Market Size by Region 3 Gaucher Disease Market Competitive Landscape 3.1 Global Gaucher Disease Sales by Manufacturers (2017-2022) 3.2 Global Gaucher Disease Revenue Market Share by Manufacturers (2017-2022) 3.3 Gaucher Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4 Global Gaucher Disease Average Price by Manufacturers (2017-2022) 3.5 Manufacturers Gaucher Disease Sales Sites, Area Served, Product Type 3.6 Gaucher Disease Market Competitive Situation and Trends 3.6.1 Gaucher Disease Market Concentration Rate 3.6.2 Global 5 and 10 Largest Gaucher Disease Players Market Share by Revenue 3.6.3 Mergers & Acquisitions, Expansion 4 Gaucher Disease Industry Chain Analysis 4.1 Gaucher Disease Industry Chain Analysis 4.2 Market Overview and Market Concentration Analysis of Key Raw Materials 4.3 Midstream Market Analysis 4.4 Downstream Customer Analysis 5 The Development and Dynamics of Gaucher Disease Market 5.1 Key Development Trends 5.2 Driving Factors 5.3 Market Challenges 5.4 Market Restraints 5.5 Industry News 5.5.1 New Product Developments 5.5.2 Mergers & Acquisitions 5.5.3 Expansions 5.5.4 Collaboration/Supply Contracts 5.6 Industry Policies 6 Gaucher Disease Market Segmentation by Type 6.1 Evaluation Matrix of Segment Market Development Potential (Type) 6.2 Global Gaucher Disease Sales Market Share by Type (2017-2022) 6.3 Global Gaucher Disease Market Size Market Share by Type (2017-2022) 6.4 Global Gaucher Disease Price by Type (2017-2022) 7 Gaucher Disease Market Segmentation by Application 7.1 Evaluation Matrix of Segment Market Development Potential (Application) 7.2 Global Gaucher Disease Market Sales by Application (2017-2022) 7.3 Global Gaucher Disease Market Size (M USD) by Application (2017-2022) 7.4 Global Gaucher Disease Sales Growth Rate by Application (2017-2022) 8 Gaucher Disease Market Segmentation by Region 8.1 Global Gaucher Disease Sales by Region 8.1.1 Global Gaucher Disease Sales by Region 8.1.2 Global Gaucher Disease Sales Market Share by Region 8.2 North America 8.2.1 North America Gaucher Disease Sales by Country 8.2.2 U.S. 8.2.3 Canada 8.2.4 Mexico 8.3 Europe 8.3.1 Europe Gaucher Disease Sales by Country 8.3.2 Germany 8.3.3 France 8.3.4 U.K. 8.3.5 Italy 8.3.6 Russia 8.4 Asia Pacific 8.4.1 Asia Pacific Gaucher Disease Sales by Region 8.4.2 China 8.4.3 Japan 8.4.4 South Korea 8.4.5 India 8.4.6 Southeast Asia 8.5 South America 8.5.1 South America Gaucher Disease Sales by Country 8.5.2 Brazil 8.5.3 Argentina 8.5.4 Columbia 8.6 Middle East and Africa 8.6.1 Middle East and Africa Gaucher Disease Sales by Region 8.6.2 Saudi Arabia 8.6.3 UAE 8.6.4 Egypt 8.6.5 Nigeria 8.6.6 South Africa 9 Key Companies Profiled 9.1 Sanofi 9.1.1 Sanofi Gaucher Disease Basic Information 9.1.2 Sanofi Gaucher Disease Product Overview 9.1.3 Sanofi Gaucher Disease Product Market Performance 9.1.4 Sanofi Business Overview 9.1.5 Sanofi Gaucher Disease SWOT Analysis 9.1.6 Sanofi Recent Developments 9.2 Takeda 9.2.1 Takeda Gaucher Disease Basic Information 9.2.2 Takeda Gaucher Disease Product Overview 9.2.3 Takeda Gaucher Disease Product Market Performance 9.2.4 Takeda Business Overview 9.2.5 Takeda Gaucher Disease SWOT Analysis 9.2.6 Takeda Recent Developments 9.3 Actelion Pharma 9.3.1 Actelion Pharma Gaucher Disease Basic Information 9.3.2 Actelion Pharma Gaucher Disease Product Overview 9.3.3 Actelion Pharma Gaucher Disease Product Market Performance 9.3.4 Actelion Pharma Business Overview 9.3.5 Actelion Pharma Gaucher Disease SWOT Analysis 9.3.6 Actelion Pharma Recent Developments 9.4 Pfizer (Protalix) 9.4.1 Pfizer (Protalix) Gaucher Disease Basic Information 9.4.2 Pfizer (Protalix) Gaucher Disease Product Overview 9.4.3 Pfizer (Protalix) Gaucher Disease Product Market Performance 9.4.4 Pfizer (Protalix) Business Overview 9.4.5 Pfizer (Protalix) Gaucher Disease SWOT Analysis 9.4.6 Pfizer (Protalix) Recent Developments 9.5 ISU ABXIS 9.5.1 ISU ABXIS Gaucher Disease Basic Information 9.5.2 ISU ABXIS Gaucher Disease Product Overview 9.5.3 ISU ABXIS Gaucher Disease Product Market Performance 9.5.4 ISU ABXIS Business Overview 9.5.5 ISU ABXIS Gaucher Disease SWOT Analysis 9.5.6 ISU ABXIS Recent Developments 10 Gaucher Disease Market Forecast by Region 10.1 Global Gaucher Disease Market Size Forecast 10.2 Global Gaucher Disease Market Forecast by Region 10.2.1 North America Market Size Forecast by Country 10.2.2 Europe Gaucher Disease Market Size Forecast by Country 10.2.3 Asia Pacific Gaucher Disease Market Size Forecast by Region 10.2.4 South America Gaucher Disease Market Size Forecast by Country 10.2.5 Middle East and Africa Forecasted Consumption of Gaucher Disease by Country 11 Forecast Market by Type and by Application (2022-2028) 11.1 Global Gaucher Disease Market Forecast by Type (2022-2028) 11.1.1 Global Forecasted Sales of Gaucher Disease by Type (2022-2028) 11.1.2 Global Gaucher Disease Market Size Forecast by Type (2022-2028) 11.1.3 Global Forecasted Price of Gaucher Disease by Type (2022-2028) 11.2 Global Gaucher Disease Market Forecast by Application (2022-2028) 11.2.1 Global Gaucher Disease Sales (K Units) Forecast by Application 11.2.2 Global Gaucher Disease Market Size (M USD) Forecast by Application (2022-2028) 12 Conclusion and Key Findings

LIST OF TABLES Table 1. Introduction of the Type Table 2. Introduction of the Application Table 3. Market Size (M USD) Segment Executive Summary Table 4. Gaucher Disease Market Size (M USD) Comparison by Region (M USD) Table 5. Global Gaucher Disease Sales (K Units) by Manufacturers (2017-2022) Table 6. Global Gaucher Disease Sales Market Share by Manufacturers (2017-2022) Table 7. Global Gaucher Disease Revenue (M USD) by Manufacturers (2017-2022) Table 8. Global Gaucher Disease Revenue Share by Manufacturers (2017-2022) Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gaucher Disease as of 2021) Table 10. Global Market Gaucher Disease Average Price (USD/Unit) of Key Manufacturers (2017-2022) Table 11. Manufacturers Gaucher Disease Sales Sites and Area Served Table 12. Manufacturers Gaucher Disease Product Type Table 13. Global Gaucher Disease Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Mergers & Acquisitions, Expansion Plans Table 15. Industry Chain Map of Gaucher Disease Table 16. Raw Materials Table 17. Midstream Market Analysis Table 18. Downstream Customer Analysis Table 19. Key Development Trends Table 20. Driving Factors Table 21. Gaucher Disease Market Challenges Table 22. Market Restraints Table 23. Global Gaucher Disease Sales by Type (K Units) Table 24. Global Gaucher Disease Market Size by Type (M USD) Table 25. Global Gaucher Disease Sales (K Units) by Type (2017-2022) Table 26. Global Gaucher Disease Sales Market Share by Type (2017-2022) Table 27. Global Gaucher Disease Market Size (M USD) by Type (2017-2022) Table 28. Global Gaucher Disease Market Size Share by Type (2017-2022) Table 29. Global Gaucher Disease Price (USD/Unit) by Type (2017-2022) Table 30. Global Gaucher Disease Sales (K Units) by Application Table 31. Global Gaucher Disease Market Size by Application Table 32. Global Gaucher Disease Sales by Application (2017-2022) & (K Units) Table 33. Global Gaucher Disease Sales Market Share by Application (2017-2022) Table 34. Global Gaucher Disease Sales by Application (2017-2022) & (M USD) Table 35. Global Gaucher Disease Market Share by Application (2017-2022) Table 36. Global Gaucher Disease Sales Growth Rate by Application (2017-2022) Table 37. Global Gaucher Disease Sales by Region (2017-2022) & (K Units) Table 38. Global Gaucher Disease Sales Market Share by Region (2017-2022) Table 39. North America Gaucher Disease Sales by Country (2017-2022) & (K Units) Table 40. Europe Gaucher Disease Sales by Country (2017-2022) & (K Units) Table 41. Asia Pacific Gaucher Disease Sales by Region (2017-2022) & (K Units) Table 42. South America Gaucher Disease Sales by Country (2017-2022) & (K Units) Table 43. Middle East and Africa Gaucher Disease Sales by Region (2017-2022) & (K Units) Table 44. Sanofi Gaucher Disease Basic Information Table 45. Sanofi Gaucher Disease Product Overview Table 46. Sanofi Gaucher Disease Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 47. Sanofi Business Overview Table 48. Sanofi Gaucher Disease SWOT Analysis Table 49. Sanofi Recent Developments Table 50. Takeda Gaucher Disease Basic Information Table 51. Takeda Gaucher Disease Product Overview Table 52. Takeda Gaucher Disease Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 53. Takeda Business Overview Table 54. Takeda Gaucher Disease SWOT Analysis Table 55. Takeda Recent Developments Table 56. Actelion Pharma Gaucher Disease Basic Information Table 57. Actelion Pharma Gaucher Disease Product Overview Table 58. Actelion Pharma Gaucher Disease Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 59. Actelion Pharma Business Overview Table 60. Actelion Pharma Gaucher Disease SWOT Analysis Table 61. Actelion Pharma Recent Developments Table 62. Pfizer (Protalix) Gaucher Disease Basic Information Table 63. Pfizer (Protalix) Gaucher Disease Product Overview Table 64. Pfizer (Protalix) Gaucher Disease Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 65. Pfizer (Protalix) Business Overview Table 66. Pfizer (Protalix) Gaucher Disease SWOT Analysis Table 67. Pfizer (Protalix) Recent Developments Table 68. ISU ABXIS Gaucher Disease Basic Information Table 69. ISU ABXIS Gaucher Disease Product Overview Table 70. ISU ABXIS Gaucher Disease Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 71. ISU ABXIS Business Overview Table 72. ISU ABXIS Gaucher Disease SWOT Analysis Table 73. ISU ABXIS Recent Developments Table 74. Global Gaucher Disease Sales Forecast by Region (K Units) Table 75. Global Gaucher Disease Market Size Forecast by Region (M USD) Table 76. North America Gaucher Disease Sales Forecast by Country (2022-2028) & (K Units) Table 77. North America Gaucher Disease Market Size Forecast by Country (2022-2028) & (M USD) Table 78. Europe Gaucher Disease Sales Forecast by Country (2022-2028) & (K Units) Table 79. Europe Gaucher Disease Market Size Forecast by Country (2022-2028) & (M USD) Table 80. Asia Pacific Gaucher Disease Sales Forecast by Region (2022-2028) & (K Units) Table 81. Asia Pacific Gaucher Disease Market Size Forecast by Region (2022-2028) & (M USD) Table 82. South America Gaucher Disease Sales Forecast by Country (2022-2028) & (K Units) Table 83. South America Gaucher Disease Market Size Forecast by Country (2022-2028) & (M USD) Table 84. Middle East and Africa Gaucher Disease Consumption Forecast by Country (2022-2028) & (Units) Table 85. Middle East and Africa Gaucher Disease Market Size Forecast by Country (2022-2028) & (M USD) Table 86. Global Gaucher Disease Sales Forecast by Type (2022-2028) & (K Units) Table 87. Global Gaucher Disease Market Size Forecast by Type (2022-2028) & (M USD) Table 88. Global Gaucher Disease Price Forecast by Type (2022-2028) & (USD/Unit) Table 89. Global Gaucher Disease Sales (K Units) Forecast by Application (2022-2028) Table 90. Global Gaucher Disease Market Size Forecast by Application (2022-2028) & (M USD) LIST OF FIGURES Figure 1. Product Picture of Gaucher Disease Figure 2. Data Triangulation Figure 3. Key Caveats Figure 4. Global Gaucher Disease Market Size (M USD), 2017-2028 Figure 5. Global Gaucher Disease Market Size (M USD) (2017-2028) Figure 6. Global Gaucher Disease Sales (K Units) & (2017-2028) Figure 7. Evaluation Matrix of Segment Market Development Potential (Type) Figure 8. Evaluation Matrix of Segment Market Development Potential (Application) Figure 9. Evaluation Matrix of Regional Market Development Potential Figure 10. Gaucher Disease Market Size (M USD) by Country (M USD) Figure 11. Gaucher Disease Sales Share by Manufacturers in 2020 Figure 12. Global Gaucher Disease Revenue Share by Manufacturers in 2020 Figure 13. Gaucher Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 14. Global Market Gaucher Disease Average Price (USD/Unit) of Key Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Players: Market Share by Gaucher Disease Revenue in 2021 Figure 16. Evaluation Matrix of Segment Market Development Potential (Type) Figure 17. Global Gaucher Disease Market Share by Type Figure 18. Sales Market Share of Gaucher Disease by Type (2017-2022) Figure 19. Sales Market Share of Gaucher Disease by Type in 2021 Figure 20. Market Size Share of Gaucher Disease by Type (2017-2022) Figure 21. Market Size Market Share of Gaucher Disease by Type in 2020 Figure 22. Evaluation Matrix of Segment Market Development Potential (Application) Figure 23. Global Gaucher Disease Market Share by Application Figure 24. Global Gaucher Disease Sales Market Share by Application (2017-2022) Figure 25. Global Gaucher Disease Sales Market Share by Application in 2021 Figure 26. Global Gaucher Disease Market Share by Application (2017-2022) Figure 27. Global Gaucher Disease Market Share by Application in 2020 Figure 28. Global Gaucher Disease Sales Growth Rate by Application (2017-2022) Figure 29. Global Gaucher Disease Sales Market Share by Region (2017-2022) Figure 30. North America Gaucher Disease Sales and Growth Rate (2017-2022) & (K Units) Figure 31. North America Gaucher Disease Sales Market Share by Country in 2020 Figure 32. U.S. Gaucher Disease Sales and Growth Rate (2017-2022) & (K Units) Figure 33. Canada Gaucher Disease Sales (K Units) and Growth Rate (2017-2022) Figure 34. Mexico Gaucher Disease Sales (Units) and Growth Rate (2017-2022) Figure 35. Europe Gaucher Disease Sales and Growth Rate (2017-2022) & (K Units) Figure 36. Europe Gaucher Disease Sales Market Share by Country in 2020 Figure 37. Germany Gaucher Disease Sales and Growth Rate (2017-2022) & (K Units) Figure 38. France Gaucher Disease Sales and Growth Rate (2017-2022) & (K Units) Figure 39. U.K. Gaucher Disease Sales and Growth Rate (2017-2022) & (K Units) Figure 40. Italy Gaucher Disease Sales and Growth Rate (2017-2022) & (K Units) Figure 41. Russia Gaucher Disease Sales and Growth Rate (2017-2022) & (K Units) Figure 42. Asia Pacific Gaucher Disease Sales and Growth Rate (K Units) Figure 43. Asia Pacific Gaucher Disease Sales Market Share by Region in 2020 Figure 44. China Gaucher Disease Sales and Growth Rate (2017-2022) & (K Units) Figure 45. Japan Gaucher Disease Sales and Growth Rate (2017-2022) & (K Units) Figure 46. South Korea Gaucher Disease Sales and Growth Rate (2017-2022) & (K Units) Figure 47. India Gaucher Disease Sales and Growth Rate (2017-2022) & (K Units) Figure 48. Southeast Asia Gaucher Disease Sales and Growth Rate (2017-2022) & (K Units) Figure 49. South America Gaucher Disease Sales and Growth Rate (K Units) Figure 50. South America Gaucher Disease Sales Market Share by Country in 2020 Figure 51. Brazil Gaucher Disease Sales and Growth Rate (2017-2022) & (K Units) Figure 52. Argentina Gaucher Disease Sales and Growth Rate (2017-2022) & (K Units) Figure 53. Columbia Gaucher Disease Sales and Growth Rate (2017-2022) & (K Units) Figure 54. Middle East and Africa Gaucher Disease Sales and Growth Rate (K Units) Figure 55. Middle East and Africa Gaucher Disease Sales Market Share by Region in 2020 Figure 56. Saudi Arabia Gaucher Disease Sales and Growth Rate (2017-2022) & (K Units) Figure 57. UAE Gaucher Disease Sales and Growth Rate (2017-2022) & (K Units) Figure 58. Egypt Gaucher Disease Sales and Growth Rate (2017-2022) & (K Units) Figure 59. Nigeria Gaucher Disease Sales and Growth Rate (2017-2022) & (K Units) Figure 60. South Africa Gaucher Disease Sales and Growth Rate (2017-2022) & (K Units) Figure 61. Global Gaucher Disease Sales Forecast by Volume (2017-2028) & (K Units) Figure 62. Global Gaucher Disease Market Size Forecast by Value (2017-2028) & (M USD) Figure 63. Global Gaucher Disease Sales Market Share Forecast by Type (2022-2028) Figure 64. Global Gaucher Disease Market Share Forecast by Type (2022-2028) Figure 65. Global Gaucher Disease Sales Forecast by Application (2022-2028) Figure 66. Global Gaucher Disease Market Share Forecast by Application (2022-2028)

•Sanofi •Takeda •Actelion Pharma •Pfizer (Protalix) •ISU ABXIS